Financhill
Back

Bicycle Therapeutics PLC Vs. NuCana PLC Industry Stock Comparison

Sell
23

BCYC
Bicycle Therapeutics PLC

Last Price:
20.57
Seasonality Move:
25.62%
Sell
27

NCNA
NuCana PLC

Last Price:
1.24
Seasonality Move:
12.07%
Sell
23
Bicycle Therapeutics PLC (BCYC) is a Sell

Is Bicycle Therapeutics PLC a Buy, Sell or Hold?

  • The current Bicycle Therapeutics PLC [BCYC] share price is $20.54. The Score for BCYC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
NuCana PLC (NCNA) is a Sell

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $1.23. The Score for NCNA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NCNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCYC Stock Price Chart

What is Bicycle Therapeutics PLC's stock price today?

  • The Bicycle Therapeutics PLC share price today is $20.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCYC is experiencing selling pressure, which indicates risk of future bearish movement.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $1.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing selling pressure, which indicates risk of future bearish movement.

BCYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.08 Sell
Relative Strength Index (14 RSI): 30.97 Sell
Chaikin Money Flow: -165518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.58 - 25.22) Sell
Bollinger Bands (100): (21.57 - 25.27) Sell

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 26.61 Sell
Chaikin Money Flow: -106181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.4 - 1.76) Sell
Bollinger Bands (100): (1.32 - 4.86) Sell

BCYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.21 Sell
20-day SMA: 22.86 Sell
50-day SMA: 23.97 Sell
200-day SMA: 23.2 Sell
8-day EMA: 21.21 Sell
20-day EMA: 22.5 Sell
50-day EMA: 23.35 Sell
200-day EMA: 22.84 Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.4 Sell
20-day SMA: 1.52 Sell
50-day SMA: 2.1 Sell
200-day SMA: 4.24 Sell
8-day EMA: 1.36 Sell
20-day EMA: 1.54 Sell
50-day EMA: 2.11 Sell
200-day EMA: 4.93 Sell

Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and a decrease next year of $0.55 per share.

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.19 per share.

Bicycle Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):